Blog - Page 503 of 5639 - QualityStocks

TuesdayFeb 20, 2024 12:00 pm

DealFlow Events Presents the Activist Investor Conference March 21 in NYC

The Activist Investor Conference will take place on March 21, 2024, at 237 Park Avenue, one of Manhattan’s premiere meeting venues The 14th annual edition of the conference features investors, corporate board members and governance experts, advisory firms, proxy solicitors and finance professionals who will delve into the latest trends within shareholder activism This year’s conference features a number of keynote presentations by experts in the field, including Patrice Bonfiglio, Sean Donohue, and Jon Feldman Shareholder activism emerged in the 1970s and 1980s as a tool to drive the process of price formation, improve corporate governance and defend minority shareholder…

TuesdayFeb 20, 2024 11:15 am

SOBRsafe Inc. (NASDAQ: SOBR) Releases Case Studies Demonstrating SOBRcheck(TM)’s Performance; CEO Provides Comprehensive Update

SOBRsafe recently published three case studies that empirically demonstrate the performance of its alcohol screening technology, SOBRcheck(TM), based on customer data, experiences, and results SOBRcheck can be used as a safe, convenient, and fast replacement for cumbersome and unhygienic breathalyzers One case study shows that SOBRcheck enabled TerraTech to achieve a 100% pass rate per week against an estimated industry average weekly violator rate of between 60% and 70% By deploying SOBRcheck, Big Horn County has been able to provide cost-effective alcohol monitoring services for more than 100 community members, while Alternatives Inc. has achieved 4x faster throughput at check-in/check-out…

TuesdayFeb 20, 2024 10:30 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Doubles Down on GLP-1 Clinical Studies for 2024; Terms 2023 as its Most Successful and Active Year of R&D

Lexaria, a global innovator in drug delivery platforms to enhance bioavailability, announced recently that it will focus on GLP-1 applications for diabetes and weight loss for the 2024 calendar year Chris Bunka, Lexaria’s CEO, has expressed his confidence in the company’s direction, reiterating the intention to demonstrate the superior performance of GLP-1 drugs processed with its patented DehydraTECH(TM) technology The company looks to build on the success of the early-stage results achieved in 2023, and looks to embark on two human pilot studies, a multi-arm 12-week animal chronic study, a human chronic weight-loss and diabetes study, as well as a…

TuesdayFeb 20, 2024 9:59 am

QualityStocksNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Serves as ‘Distinguished Marketplace Partner’ at Seventh Annual Geotab Connect 2024 Gathering

Freight Technologies (NASDAQ: FRGT), a technology company whose custom-developed Fr8App, an industry-leading freight-matching platform powered by artificial intelligence (“AI”) and machine-learning and offering a real-time portal for B2B cross-border shipping and domestic shipping within the USMCA region, is participating in this month’s Geotab Connect 2024 event. The company received a special invitation to participate in the prestigious event, which is hosted by Geotab, a global leader in connected transportation solutions. The event was held from Feb. 14–16 in Las Vegas. According to the announcement, the three-day Geotab Connect 2024 event is designed to offer unparalleled insights into the ever-evolving landscape…

TuesdayFeb 20, 2024 9:45 am

PaxMedica Inc. (NASDAQ: PXMD) Developing Pipeline of Products to Address Prevalence and Unmet Medical Needs of Autism Spectrum Disorder

The CDC estimates that the prevalence of ASD in the United States is 1 in 36 children, with no approved pharmacologic treatments targeting the cause and symptoms PaxMedica is developing novel anti-purinergic therapies for the treatment of ASD and other serious conditions with intractable neurologic symptoms, and is on a promising path to address the unmet medical needs and bring hope to millions Company CEO Howard Weisman recently shared insights into PaxMedica’s achievements and advancements in a Fireside Chat video, underscoring the company’s commitment to groundbreaking therapies and transformative solutions The prevalence of autism spectrum disorder (“ASD”) in the United…

TuesdayFeb 20, 2024 9:00 am

Mullen Automotive Inc. (NASDAQ: MULN) Displays Vehicles for First Time at CES, Unveils Newest EV Offering

Mullen debuted its FIVE RS at this year’s CES show in Las Vegas Several car and auto publications reported on the unveiling of the new model Mullen anticipates beginning production of the FIVE RS in late 2025, with sales commencing in mid-2026 For the first time ever, Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, exhibited its line of commercial and consumer EVs at the Consumer Electronics Show(R) (“CES”) in Las Vegas. In addition to displaying its line of vehicles, the company also debuted its high-performance EV crossover, the Mullen FIVE RS; the world debut of the new…

FridayFeb 16, 2024 3:23 pm

QualityStocksNewsBreaks – Vision Marine Technologies Inc. (NASDAQ: VMAR) Spotlighted as ‘Disruptive Force’ in Electrification of Recreational Boating

Vision Marine Technologies Inc. (NASDAQ: VMAR) was featured in the latest episode of The GotStocks Podcast published by NetworkNewsWire (“NNW”), one of 60+ brands within the Dynamic Brand Portfolio @ IBN (Investor Brand Network). The episode discusses a publication entitled “The Electrifying Rise of Electric Boats,” which spotlights Vision Marine Technologies as the company that offers the first fully electric, purpose-built outboard powertrain system of its type, with unparalleled capabilities. “The raucous rumble of combustion engines is fading, systematically replaced by the high-performance hum of electric propulsion that’s transforming every aspect of transport. Electric cars have moved mainstream with both…

FridayFeb 16, 2024 2:24 pm

QualityStocksNewsBreaks – Correlate Energy Corp. (CIPI) Anticipates Continued Success, Leadership Positioning on Heels of Key Appointments

Correlate (OTCQB: CIPI), a tech-enabled development, finance and fulfillment platform for distributed energy solutions across North America, recently announced the appointment of Johan Themaat to the role of CFO and welcomed Dr. Christine Gulbranson and Alina Zagaytova to its board of directors. “[Johan Themaat] will lend his years of experience, having held key positions and executed integral roles at prominent companies that include, but are not limited to, Mission Energy, NGL Energy Partners and RBS, among others… Dr. Christine, the founder of Nova Global Ventures, will lend her knowledge and expertise on AI and disruptive technology while also providing guidance…

FridayFeb 16, 2024 12:08 pm

QualityStocksNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Collaboration with Momentum Worldwide Featured in Fast Company Column

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in the development and delivery of quantum computing systems, and Momentum Worldwide, a global experiential agency within Interpublic Group of Companies (NYSE:IPG), have been working together on a pilot project to optimize experiential marketing tours and events. Momentum Worldwide provides large-scale experiential marketing and promotional tours for an array of well-known clients. The pilot project was featured in a recent “Fast Company” column from Momentum Worldwide global chief technology officer Jason Snyder, highlighting how quantum computing can be a practical solution for business problems. Titled “How Quantum Computing Technology Solves Real-World Business…

FridayFeb 16, 2024 11:41 am

QualityStocksNewsBreaks — SenesTech Inc. (NASDAQ: SNES) Announces Plans to Release Q4, FY 2023 Financial Results

SenesTech (NASDAQ: SNES), the leader in fertility control to manage animal-pest populations, will be reporting its financial results for its fourth quarter and fiscal year 2023, or the period ended Dec. 31, 2023. The company has scheduled the release of the report for after market close on Feb. 21, 2024. In addition to releasing the report, the company has scheduled a teleconference for that same date to review the report; the call will begin at 5 p.m. ET. Those interested in participating in the call can dial (844) 308-3351 or (412) 317-5407. A replay of the teleconference will be available…

Site Search

Company Search